Finnrick - Ensuring a Safer and More Transparent Supply Chain
Chimera Peptides

Chimera Peptides

Retatrutide

Finnrick tested 8 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Chimera Peptides between 13 Oct 2025 and 16 Mar 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
Chimera Peptides
Retatrutide
Tested 8 Samples
Last test 16 Mar 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Chimera Peptides

Samples are tested in commercial labs

Tests Count

8

Scores

AVG6.9MIN4.7MAX8.0

Last

16 Mar 2026

First

13 Oct 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
16 Mar 2026View7.860mg58.5mg-2.5%99.80%(no batch ID)No Label / Silver Crimp / White CapLab GPublic
22 Feb 2026View6.520mg22mg+10.0%99.90%(no batch ID)No Label / Silver Crimp / Violet CapLab EPublic
20 Feb 2026View4.720mg24.8mg+24.0%99.80%(no batch ID)No Label / Silver Crimp / Violet CapLab GPublic
22 Jan 2026View7.240mg43mg+7.5%99.90%(no batch ID)No Label / Silver Crimp / Red CapLab GPublic
29 Dec 2025View7.310mg10.3mg+3.0%99.60%(no batch ID)White Label / Silver Crimp / Gren Cap Lab GPublic
29 Dec 2025View7.315mg15.1mg+0.7%99.60%(no batch ID)White Label / Silver Crimp / Clear Cap Lab GPublic
5 Dec 2025View6.360mg66.4mg+10.7%99.90%(no batch ID)No Label / Silver Crimp / Yellow CapLab GPublic
13 Oct 2025View8.020mg18.2mg-9.0%99.60%Purple CapsNo Label / Silver Crimp / Purple Cap Lab GPublic